Biography and Research Information
OverviewAI-generated summary
Qudes Al-Anbaky's research focuses on understanding and mitigating the adverse effects of medical treatments, particularly intestinal radiation toxicity. Al-Anbaky has investigated the potential of geranylgeranyl transferase inhibitors as a therapeutic strategy to reduce this toxicity, as evidenced by the 2025 publication "Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity." This work is conducted in collaboration with researchers at the University of Arkansas for Medical Sciences, including Rupak Pathak, Kathleen E. McGinness, Enoch K. Larrey, and H. Terence Cook, with whom Al-Anbaky shares a publication.
Metrics
- Publications: 1
Selected Publications
-
Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity (2025)
Collaboration Network
Top Collaborators
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
- Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity
Similar Researchers
Based on overlapping research topics